Stability of Essential Drugs in Tropical Climates: Zimbabwe - EDM Research Series No. 013
(1994; 86 pages) Voir le document au format PDF
Table des matières
Afficher le documentAbbreviations
Afficher le document1. Summary
Ouvrir ce répertoire et afficher son contenu2. Introduction
Ouvrir ce répertoire et afficher son contenu3. Study design and methods
Afficher le document4. Results
Fermer ce répertoire5. Discussion
Afficher le document5.1 Drugs without failures
Afficher le document5.2 Drugs with a low rate of failures
Afficher le document5.3 Drugs with a high rate of failures
Afficher le document5.4 Assumptions and limitations of data
Afficher le document5.5 Pipeline times, expiry and shelf-life considerations
Ouvrir ce répertoire et afficher son contenu6. Conclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuAnnexes
 

5.2 Drugs with a low rate of failures

Ampicillin capsules

No problem was seen in the initial quality of ampicillin capsules: 10 GMS samples were within specification limits (92.5-110%). This drug is not available at PHC level and turnover at hospitals was fast One (4%) of 28 facility samples was marginally below the lower assay limit (assay 92.4%) at age 28.5 months. This was the only sample which expended more than half the three year shelf-life.

The 11 paired samples showed no consistent loss of potency after a mean interval of 5.3 months. There were no signs of instability, but facility samples were in the early part of a three year shelf-life (mean age 8.6 months).

The single failure may be accounted for by a measurement error. A recent policy decision means that ampicillin capsules will no longer be supplied in Zimbabwe, amoxicillin capsules will be used instead.

Doxycycline capsules

This was a hospital-only drug supplied by a single manufacturer. One batch was received in GMS with more than half the shelf-life expended. Initial potency was within the wide specification limits (90-120% USP) with a mean assay of 102.1%, However, the sample size was small (only five GMS samples were tested). The 15 facility samples tended towards the upper limit of specifications: mean assay 110.1% with a mean age of 17.3 months. Two (13%) facility samples failed, but only one was below the lower limit (82.7%) at age 21.9 months; the other was above. 60% of facility samples had expended more than half of their shelf-life (two or three years). The results for five expired samples showed a lower mean assay (97.8%) at mean age 27.7 months.

There was no evidence of instability in five GMS/facility sample pairs after a mean interval of 10.1 months, but the sample size was small. The mean assay for both GMS and facility samples had wide confidence limits (plus or minus 5%) which made the interpretation of results difficult. A measurement error may be considered for the single low failure.

A policy decision to replace tetracycline capsules with doxycycline capsules at the PHC level will increase the volume of doxycycline used.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013